MARKETSAurobindo Pharma Gains 2% After US Plant Clears FDA ReviewTabassum ChaudharyAugust 17, 2026August 17, 2026 August 17, 2026August 17, 2026 Aurobindo Pharma shares gained 2% on Monday morning after a US-based unit, Aurolife Pharma, cleared an FDA plant inspection with VAI status. The gain follows...